THAR: Tharimmune, Inc. Stock

by  •  • Comments Off on THAR: Tharimmune, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2.41
Enterprise Value ($M) -5.48
Book Value ($M) 6.69
Book Value / Share 5.83
Price / Book 0.36
NCAV ($M) 6.69
NCAV / Share 5.83
Price / NCAV 0.36

Profitability (mra)
Return on Invested Capital (ROIC) -1.33
Return on Assets (ROA) -2.80
Return on Equity (ROE) -5.05

Liquidity (mrq)
Quick Ratio 5.28
Current Ratio 5.28

Balance Sheet (mrq) ($M)
Current Assets 8.26
Assets 8.26
Liabilities 1.56
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Tang Capital Partners Lp 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-23 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-10-07 5,644 18,819 29.99
2024-10-04 3,108 16,721 18.59
2024-10-03 2,707 19,473 13.90
2024-10-02 2,220 8,779 25.29

(click for more detail)

Similar Companies
TENX – Tenax Therapeutics, Inc. TFFP – TFF Pharmaceuticals, Inc.
TGTX – TG Therapeutics, Inc. THTX – Theratechnologies Inc.
TIL – Instil Bio, Inc.


Financial data and stock pages provided by
Fintel.io